The estimated Net Worth of Scott Alexander O'brien is at least 4.14 百万$ dollars as of 27 January 2021. Scott brien owns over 180 units of GenMark Diagnostics Inc stock worth over 3,484,959$ and over the last 5 years Scott sold GNMK stock worth over 651,265$.
Sign up
Scott brien GNMK stock SEC Form 4 insiders trading
Scott has made over 15 trades of the GenMark Diagnostics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Scott sold 180 units of GNMK stock worth 2,531$ on 27 January 2021.
The largest trade Scott's ever made was selling 36,570 units of GenMark Diagnostics Inc stock on 17 August 2020 worth over 562,447$. On average, Scott trades about 2,877 units every 13 days since 2020. As of 27 January 2021 Scott still owns at least 144,965 units of GenMark Diagnostics Inc stock.
You can see the complete history of Scott brien stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Scott brien's mailing address?
Scott's mailing address filed with the SEC is 5964, La Place Court, Carlsbad, San Diego County, California, 92008, United States of America.
Insiders trading at GenMark Diagnostics Inc
Over the last 14 years, insiders at GenMark Diagnostics Inc have traded over 27,572,889$ worth of GenMark Diagnostics Inc stock and bought 454,838 units worth 2,182,328$ . The most active insiders traders include Hany Massarany、Jon Faiz Kayyem、Kevin C Oboyle. On average, GenMark Diagnostics Inc executives and independent directors trade stock every 5 days with the average trade being worth of 141,403$. The most recent stock trade was executed by Michael Gleeson on 14 April 2021, trading 27,667 units of GNMK stock currently worth 326,471$.
What does GenMark Diagnostics Inc's logo look like?
Complete history of Scott brien stock trades at GenMark Diagnostics Inc
GenMark Diagnostics Inc executives and stock owners
GenMark Diagnostics Inc executives and other stock owners filed with the SEC include:
-
Scott Mendel,
President, Chief Executive Officer, Director -
Johnny Ek,
Chief Financial Officer -
Michael Gleeson,
Senior Vice President, Corporate Accounts -
Eric Stier,
Senior Vice President, General Counsel, Secretary -
James Fox,
Non-Executive Independent Director -
Kevin O'Boyle,
Independent Chairman of the Board -
Lisa Giles,
Independent Director -
Daryl Faulkner,
Independent Director -
Michael Kagnoff,
Independent Director -
Tyler Jensen,
Senior Vice President - Engineering and Product Technical Support -
Jon Faiz Kayyem,
President & CEO -
Jennifer Anne Williams,
SVP Global Operations -
Wade R. Stevenson,
SVP, North America Sales -
Brian Andrew Mitchell,
SVP, Operations -
Christine Shaw,
VP, Assay Development -
John Frederick Ek,
Chief Financial Officer -
Richard B Slansky,
Chief Financial Officer -
Stephen T Worland,
Director -
Jeffrey Alan Hawkins,
SVP, Marketing & Bus Dev -
Ingo Chakravarty,
SVP, International -
Christopher M Gleeson,
Director -
James B. Mc Nally,
SVP, Marketing and Bus. Dev. -
Jorge Garces,
SVP, Research & Development -
Paul Ross,
CFO & Secretary -
Pankaj Singhal,
Sr. VP, Product Dev & Mftg -
Matthew Robert Cohen,
SVP, Gen Counsel & Secretary -
John Bellano,
SR. VP, Commercial Operations -
Steven J Kemper,
CFO, Treasurer & Secretary -
Bradley Calvin,
Senior VP, Global Marketing -
Scott Alexander O'brien,
SVP, Global Mktg & Int'l Sales -
Hany Massarany,
President and CEO -
Sarah Hollis Winkler,
VP, Human Resources -
Alan Baer Maderazo,
VP, Qual, Reg, & Clin Affairs -
Michael John Harkins,
SVP, Sales -
Abdul Chohan,
SVP Operations